Study Evaluating the Efficacy and Safety of WID-RGC20(Cariprazine) in Patients With Schizophrenia
Clinical trial NCT05168007 · UNKNOWN
Trial details
- NCT number
- NCT05168007
- Sponsor
- Whanin Pharmaceutical Company
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-19
- Primary completion
- 2023-07-17
- Enrollment
- 342
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.